APA

Bartmann C., Janaki Raman S. R., Flöter J., Schulze A., Bahlke K., Willingstorfer J., Strunz M., Wöckel A., Klement R. J., Kapp M., Djuzenova C. S., Otto C. & Kämmerer U. (2018). Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation. : Cancer & metabolism.

Chicago

Bartmann Catharina, Janaki Raman Sudha R, Flöter Jessica, Schulze Almut, Bahlke Katrin, Willingstorfer Jana, Strunz Maria, Wöckel Achim, Klement Rainer J, Kapp Michaela, Djuzenova Cholpon S, Otto Christoph and Kämmerer Ulrike. 2018. Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation. : Cancer & metabolism.

Harvard

Bartmann C., Janaki Raman S. R., Flöter J., Schulze A., Bahlke K., Willingstorfer J., Strunz M., Wöckel A., Klement R. J., Kapp M., Djuzenova C. S., Otto C. and Kämmerer U. (2018). Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation. : Cancer & metabolism.

MLA

Bartmann Catharina, Janaki Raman Sudha R, Flöter Jessica, Schulze Almut, Bahlke Katrin, Willingstorfer Jana, Strunz Maria, Wöckel Achim, Klement Rainer J, Kapp Michaela, Djuzenova Cholpon S, Otto Christoph and Kämmerer Ulrike. Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation. : Cancer & metabolism. 2018.